Talent Pool

Contributed by:

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.

Pharma POOL
Steve Andrzejewski
Eric J. Bruce
Rick Kelly
Dan McCall
Robert Murphy
Adriana Sax

King Pharmaceuticals Hires and Promotes

King, Bristol, Tenn., a vertically integrated branded pharmaceutical company, has appointed Steve Andrzejewski to chief commercial officer. His new responsibilities include business development for the company’s Meridian division. Mr. Andrzejewski joined King in May 2004 as corporate head of commercial operations. Eric J. Bruce has joined the company as corporate head of technical operations, responsible for overseeing manufacturing, quality, and supply-chain logistics. He has more than 20 years of experience in manufacturing and supply-chain management. King has promoted Rick Kelly to senior product director with responsibility for marketing and life-cycle management programs in the company’s cardiovascular/endocrinology therapeutic area. He previously worked at Roche, where he held roles of increasing responsibility in the areas of sales, sales management, account management, and marketing. Dan McCall has been promoted to senior VP of sales and field operations, responsible for leading King’s national primary care and specialty sales, as well as sales and marketing operations. Since joining the company in 1997, Mr. McCall has held several positions, most recently serving as senior VP, sales, eastern division. King has hired Robert Murphy as VP of sales, with responsibility for primary care and specialty sales in the company’s eastern division. Most recently, he was VP of sales at Bone Care International. Adriann Sax has been appointed executive VP of business development and strategic planning. She continues to have responsibility for strategic marketing, market research, and forecasting. Ms. Sax joined King in April 2005 as senior VP of strategic marketing and has 20 years of experience in pharmaceutical marketing. Rich Daly TAP Veteran Returns to Senior Marketing Role TAP Pharmaceutical Products, Lake Forest, Ill., a joint venture between Abbott and Takeda Pharmaceutical, has appointed Rich Daly as VP of marketing and commercial strategy. He was senior VP of marketing for Takeda Pharmaceuticals North America. He has a bachelor’s degree in science and microbiology from the University of Notre Dame and an MBA from the Kellogg School of Management at Northwestern University. Dr. Louis M. Renzetti Roche Appoints Head of Respiratory and Inflammation Research Roche, Nutley, N.J., a research-oriented healthcare group with core businesses in pharmaceuticals and diagnostics, has named Louis M. Renzetti, Ph.D., VP of research, respiratory and inflammation. He focuses on identifying new drug targets and opportunities for the treatment of severe asthma, multiple sclerosis, inflammatory bowel disease, and chronic obstructive pulmonary disease. Dr. Renzetti has been with Roche for 14 years, most recently as senior research director. He has a Ph.D. in physiology from the Temple University School of Medicine and a B.A. from the University of Pennsylvania. Dr. Harold H. Shlevin Solvay Names Global Senior VP Solvay Pharmaceuticals, a research-driven pharmaceutical company based in Marietta, Ga., has promoted Harold H. Shlevin, Ph.D., to global senior VP of the newly formed global regulatory, external affairs, safety, and quality strategies (RESQS) organization. Dr. Shlevin previously served as president and CEO of Solvay Pharmaceuticals in the United States. He continues to serve as a member of the board of directors for the U.S. pharmaceuticals organization and has assumed additional responsibilities as a member of two corporate committees. Dr. Moncef Slaoui GlaxoSmithKline Plans R&D Succession GlaxoSmithKline will promote Moncef Slaoui, Ph.D., to chairman of research and development, effective June 1, 2006. Dr. Slaoui, 46, also will join the corporate executive team and the company’s board of directors. He succeeds Dr. Tadataka (Tachi) Yamada, who is retiring to become executive director of the global health program at the Bill and Melinda Gates Foundation. A 17-year GSK veteran, Dr. Slaoui currently serves as senior VP of worldwide business development and external alliances for the company’s R&D organization. He earned his Ph.D. in molecular biology and immunology from the Universite Libre de Bruxelles, Belgium, and completed postdoctoral studies at Harvard Medical School and Tufts University School of Medicine. Biopharmaceutical POOL Dr. Christophe Bianchi Grant Bogle Anna Protopapas Millennium Makes Key Appointments Millennium Pharmaceuticals, a biopharmaceutical company based in Cambridge, Mass., has appointed Christophe Bianchi, M.D., as executive VP for commercial operations. He also has become an executive officer of the company and a member of the leadership team. Dr. Bianchi has 17 years of experience in the U.S. pharmaceutical industry, most recently as head of the U.S. oncology business unit at Sanofi-Aventis. He earned his M.D. from the University of Reims-Champagne and his MBA from the Wharton School at the University of Pennsylvania. Millennium has promoted Grant Bogle to senior VP of sales and marketing for Velcade. He joined the company in 2004 as the head of sales and marketing for Integrilin Injection. Previously, he was president of ViaCord. Millennium also has appointed Anna Protopapas, as senior VP of corporate development, executive officer, and member of the leadership team. Since Ms. Protopapas joined Millennium in 1997, she has been a key driver in forging partnerships that have generated significant revenue and value for the company, including collaborations with J&J, Aventis Pharmaceuticals, and Abbott Laboratories. Richard Crowley Joseph L. Fischer ImClone Appoints Key Executives ImClone Systems, New York, has promoted Richard Crowley to senior VP of biopharmaceutical operations. Mr. Crowley oversees the biologics manufacturing operations for ImClone, a biopharmaceutical company dedicated to developing breakthrough biologic medicines in the area of oncology. Mr. Crowley joined ImClone Systems in 2000 as assistant VP of manufacturing. He replaces Joseph Tarnowski, Ph.D., who has taken a position at Bristol-Myers Squibb. ImClone also has appointed Joseph L. Fischer as interim CEO. He replaces Philip Frost, M.D., Ph.D., who remains as executive VP and chief scientific officer. Mr. Fischer brings to the company more than 20 years of global managerial and operational experience, including a variety of senior management roles at Johnson & Johnson. Dr. Ronald W. Ellis Avant Appoints Senior VP Avant Immunotherapeutics has appointed Ronald W. Ellis, Ph.D., as senior VP of research and development. Based in Needham, Mass., Avant discovers, develops, and commercializes vaccines and immunotherapeutics. Dr. Ellis previously was with ID Biomedical, where he was a senior VP of development and general manager. He has a B.A. from the University of Chicago, a Ph.D. from Cornell University, and an MBA from the University of Maryland. Anthony E. Maida III Carlo Montagner Dr. Patrick Soon-Shiong Nicole S. Williams Abraxis BioScience Forms Senior Management Team Abraxis BioScience, a fully integrated, global biopharmaceutical company formed through the merger of American Pharmaceutical Partners (APP) and American BioScience (ABI), has named its senior-management team. Anthony E. Maida III, has been named division president of Abraxis BioCapital, which focuses on pursuing strategic collaborations of early-stage technologies from academia and start-up biotechnology companies through in-licensing or acquisitions to leverage the manufacturing, clinical trial, and regulatory capabilities of Abraxis BioScience. He most recently was the chairman of Dendri Therapeutics. He has an M.A. in toxicology from San Jose State University, an MBA from the University of Santa Clara, and B.A. degrees from San Jose State University and the University of Santa Clara. Carlo Montagner has been named president of Abraxis Oncology. He previously was executive VP and global business unit head of oncology for Schering AG. Patrick Soon-Shiong, M.D., chairman and CEO of APP and ABI, serves as chairman and CEO of the merged entity. He also oversees the Abraxis Research division. Additionally, Nicole S. Williams has been appointed division president, American Pharmaceutical Partners, which focuses on multi-source injectable products, and chief financial officer of Abraxis BioScience. Ms. Williams served as chief financial officer of APP since August 2002. She has an MBA from the University of Chicago and graduate and undergraduate degrees in political science and economics from the University of Geneva in Switzerland. Dr. Akshay K. Vaishnaw Alnylam Appoints VP, Clinical Research Alnylam Pharmaceuticals, a RNAi therapeutics company based in Cambridge, Mass., has appointed Akshay K. Vaishnaw, M.D., Ph.D., to the position of VP of clinical research. Dr. Vaishnaw spent seven years at Biogen Idec, most recently as senior director of translational medicine. He received his M.D., with distinctions in pathology and medicine, from the University of Wales College of Medicine and his Ph.D. in molecular immunology from the University of London. He also earned an executive MBA from Harvard Business School. Specialty POOL F. Michael Ball Raymond Diradoorian Allergan Promotes Key Leaders Allergan, a technology-driven, specialty pharmaceutical company based in Irvine, Calif., has appointed F. Michael Ball president. He replaces David E.I. Pyott, who has maintained his positions as CEO and chairman of the board. Mr. Ball joined Allergan in 1995 and most recently served as executive VP and president of pharmaceuticals. Raymond Diradoorian has been promoted to executive VP of global technical operations. A 25-year Allergan veteran, he most recently served as Allergan’s senior VP, global technical operations, responsible for the global network of manufacturing plants, quality assurance, and environmental health and safety. Clayton Fletcher Dr. Debra Gayda Dr. Stephen Villano ViroPharma Broadens Senior Management ViroPharma, a specialty pharmaceutical company in Exton, Pa., has promoted Clayton Fletcher to VP of business development. He joined ViroPharma in 2001 as project leader. He has M.S. and B.A. degrees in biology from Wake Forest University. Debra Gayda, Ph.D., has been appointed VP of regulatory affairs, responsible for defining, planning, and orchestrating ViroPharma’s regulatory strategy. She spent nine years at Sanofi-Aventis, most recently as VP of regulatory development. She has a B.S. in biological science from Purdue University and a Ph.D. in toxicology from the University of Wisconsin. Additionally, Stephen Villano, M.D., has been promoted to VP of clinical research and development. He served as ViroPharma’s medical director since 2001. He holds a B.S. from Fairfield University and a medical degree from Johns Hopkins University School of Medicine. Christy Taylor Dey Names Sales and Marketing Leader Dey, Napa, Calif., a specialty pharmaceutical company focused on respiratory therapies, has promoted Christy Taylor to senior VP of sales, marketing, and business development. Previously, she was senior VP of sales. She earned her B.S. in business from St. Mary’s College and her master’s in international business from the American Graduate School of International Management. Dr. Arthur Tzianabos Shire Builds Management Team Shire, a specialty pharmaceutical company with headquarters in Basingstoke, United Kingdom, has hired Arthur Tzianabos, Ph.D., as head of discovery research at Shire Human Genetic Therapies in Cambridge, Mass. He is responsible for identifying new research opportunities and collaborations. Dr. Tzianabos comes to Shire from Harvard Medical School, where he was an associate professor of medicine. He also is a cofounder of Boston-based Regulion Therapeutics. Emerging POOL Gerald W. Bruce NitroMed Names Sales VP Gerald W. Bruce has been appointed VP of sales at NitroMed, Lexington, Mass., a research-based emerging pharmaceutical company. Mr. Bruce, 49, most recently was VP of private-sector strategy and accounts at Bristol-Myers Squibb. He is a graduate of Lincoln University, where he earned a B.A. in business administration. Eric L. Sorkin Immtech Appoints CEO Eric (Rick) L. Sorkin has been named CEO of Immtech International, Vernon Hills, Ill., a pharmaceutical company working to commercialize drugs to treat infectious diseases. Mr. Sorkin, who has been a director of Immtech for six years, has retained his role as chairperson of the company’s board. Previously, he spent 11 years with Dean Witter, now a subsidiary of Morgan Stanley. Mr. Sorkin is a graduate of Yale University with a B.A. in economics. Dr. Larry D. Witte Cylene Appoints Chief Scientific Officer Cylene Pharmaceuticals has hired Larry D. Witte, Ph.D., as chief scientific officer. Based in San Diego, Cylene discovers, develops, and commercializes first-in-class, small-molecule drugs to treat life-threatening diseases, particularly cancer. Dr. Witte most recently served as VP of research. Dr. Witte earned his Ph.D. from Iowa State University. Agency POOL Nicholas Avallone Shanika Bradley Rachel Callahan Abelson-Taylor Promotes Three Abelson-Taylor, a Chicago-based medical advertising agency, has promoted Nicholas Avallone to assistant account executive for Genentech’s oncology product Rituxan. He joined Abelson-Taylor in May 2005 as a clinical research associate. He has a B.S. in biochemistry from the University of Kansas. The agency also has promoted Shanika Bradley to account supervisor, responsible for the European launch of Tarceva. Ms. Bradley began her career at Abelson-Taylor in 2002 as an account executive and most recently served as senior account executive. She has a B.A. in psychology from Northwestern University. Rachel Callahan has been promoted to account executive for the Takeda product Actos, a diabetes drug. She most recently was assistant account executive for Amgen’s Aranesp. She holds a B.S. in business administration from the University of Notre Dame, where she graduated magna cum laude. Joanne Chaseman Bloomstein Marybeth Nibley Angela Veliky B&Y Builds Staff Joanne Chaseman Bloomstein has been named director of client services at B&Y Communications, Montclair, N.J., a public-relations firm. She is responsible for media relations, client projects, and business development. Marybeth Nibley has been appointed media relations director at B&Y, responsible for planning and implementing communications strategies, media outreach, and senior-level writing. She most recently was with the CNN/Money Website. Additionally, Angela Veliky has been promoted to account executive at B&Y. She had previously served the firm as an intern since 2004. She is a graduate of Caldwell College with a degree in communication arts. Brian Carley Heather DeBruin Nikki Leifer Julia A. Olff HealthEd Hires and Promotes HealthEd, Clark, N.J., a developer of patient-education programs for pharmaceutical and healthcare marketers, has named Brian Carley as associate creative director. He is responsible for the overall conceptual design and development of creative initiatives for both traditional print media and interactive media. Before joining HealthEd, Mr. Carley was the senior art director and flash designer for Organic. Heather DeBruin also has joined HealthEd as a senior account supervisor, responsible for all aspects of account service and maintenance. Previously, she supervised marketing efforts at Gillespie/MRM-Princeton. Additionally, HealthEd has hired Nikki Leifer as VP of account supervision. Ms. Leifer is responsible for the management and growth of the company’s pharmaceutical accounts. Most recently, Ms. Leifer managed several accounts at DVC Worldwide. HealthEd has promoted Julia A. Olff to director of health education. She previously served as project manager for HealthEd. Ms. Olff is a certified health education specialist (CHES). Chelcy Dillon-Sherman Scott Petrie S&R Communications Promotes Chelcy Dillon-Sherman has been promoted to art director at S&R Communications Group, a full-service healthcare marketing and communications company based in Durham, N.C. She originally joined the firm in 2004 as a graphic designer and most recently served as junior art director. She is a graduate of Peace College. S&R also has promoted Scott Petrie to associate creative director, design, responsible for supervising the art department. He has worked with the agency since 2004 as an art director. Beatrice Ellerin Wes Wilkes Interbrand Wood Adds Staff Interbrand Wood Healthcare, a global brand consultancy, has appointed Beatrice (Bunny) Ellerin as managing director in the New York office, responsible for the rxmark brand research and intelligence business. She previously was with PPD, where she was executive director of online marketing and education. She has a B.A. from Columbia University and an MBA from Harvard University. Wes Wilkes also has joined Interbrand as managing director, healthcare strategy, in the agency’s New York office. He works with his team to grow the healthcare strategic brand consulting business. Mr. Wilkes previously was at Pfizer, where he worked on brand development and management. He earned a B.Sc. in biomedical sciences from the College of Veterinary Medicine and an MBA from Mays Business School. Nanette Foster Mike Myers Bonnie Stofer Palio Makes Key Appointments Palio Communications, a subsidiary of inChord Communications, a Ventiv Health company, has promoted Nanette Foster to VP/senior brand planner. Based in Saratoga Springs, N.Y., Palio is a full-spectrum advertising and communications agency. Since joining the agency, Ms. Foster has been involved in developing the brand strategy group. Previously she worked as a brand consultant for Interbrand. She has a bachelor’s degree from Russell Sage College. Palio also has promoted Mike Myers to president. Mr. Myers, who joined Palio in 1999, most recently was the agency’s executive VP/managing director, client service. He has an MBA from the University of Southern California and a B.S. in business administration from the University of Arizona. Additionally, Bonnie Stofer has been appointed senior VP of business development and integration. She focuses on new business strategy and employee-training efforts and talent management. Before joining Palio, she was the director of account management for Buck & Pulleyn. Ms. Stofer has a bachelor’s degree from the University of Connecticut. Joe Garamella Kathy Jenkins Rob Rogers Sudler & Hennessey Reorganizes Creative Staff Sudler & Hennessey U.S., New York, has reorganized staff in its creative department. A global healthcare marketing and communications organization, S&H is a WPP company within the Young & Rubicam Brands group. The agency has promoted Joe Garamella to executive creative director. He most recently served as executive VP, creative director. Previously, he spent five years working for a West Coast biotechnology boutique agency. Kathy Jenkins has joined the agency in the newly created role of brand catalyst. She comes to S&H from the Quantum Group, where she was a founder and chief creative officer. S&H also has appointed Rob Rogers as chief creative officer in the United States. Before this appointment, he served as president of S&H, Asia/Pacific, a position he retains. Before rejoining the agency in 2003, he was chief creative officer, worldwide, Grey Healthcare Group. Cameron Haggerty Scott Kim Ryan Orsini Adam Schirmer Ferguson Hires and Promotes Ferguson, Parsippany, N.J., CommonHealth’s founding professional advertising and promotion unit, has promoted Cameron Haggerty to account executive from assistant account executive. Ms. Haggerty has been with Ferguson since 2004. Ferguson has hired Scott Kim as an art director, responsible for concept development and implementation. Previously, he was senior creative designer at Aetrex Worldwide. Ryan Orsini has been promoted to account supervisor from senior account executive. He has been with the agency for one year. Adam Schirmer has been promoted to group art director from senior art director. Sidney HO Ignite Health Appoints Brand Strategy Director Ignite Health, Irvine, Calif., an independent healthcare advertising agency, has appointed Sidney Ho to the position of director of brand strategy. Mr. Ho, who has more than 12 years of experience, provides strategic guidance to client marketing groups on brand positioning and tactical planning. Mr. Ho joins Ignite after seven years at ViroLogic (now Monogram Biosciences), where he most recently was director of communications. He has a B.A. in economics from the University of California at Los Angeles. John Hondroulis Blue Diesel Names Account Director John Hondroulis has been appointed account director at Blue Diesel, Westerville, Ohio, an interactive marketing company and part of the inChord Communications division of Ventiv Health. He is responsible for leading the strategy and development of marketing initiatives. Previously, Mr. Hondroulis was district sales manager at Behringer USA. He has a bachelor’s degree from Ohio State University. Michele Lentz Shaw Hires VP Shaw Science Partners, a science-based pharmaceutical-marketing agency located in Atlanta, has hired Michele Lentz as VP, senior account director. Ms. Lentz most recently served as VP of client services for Group DCA. She received her B.S. in business administration/marketing from Kutztown University. Renee McKeon Bob Robinson imc2 Promotes Creative Leaders imc2, an independent, digital marketing agency based in Dallas, has promoted Renee McKeon to VP, user experience. She joined the agency in 2000. Bob Robinson has been promoted to executive creative director, responsible for crafting creative solutions for clients. Before joining the agency in 2003, Mr. Robinson was regional VP at Divine. Donna Mongiello Supply Marketing Builds Salesforce Supply Marketing, a full-service marketing and communications company based in King of Prussia, Pa., has hired Donna Mongiello as director of sales. A registered nurse for more than 17 years, Ms. Mongiello previously served as clinical director of two home-care companies, as well as president of her own consulting company. Dr. Katherine O’Neill Group DCA Appoints Market Research President Group DCA, an online healthcare communications company based in Montclair, N.J., has appointed Katherine O’Neill, Ph.D., as president of Park Street Research, the company’s online market-research division. Dr. O’Neill has more than 17 years of experience and operated her own market-research and consulting firm, O’Neill Consulting. She has a Ph.D. in experimental psychology from the University of Rhode Island and a certificate in medical marketing from UCLA. Joe Santoro Cadient Appoints Creative Director Cadient Group, West Conshocken, Pa., a strategic, interactive marketing agency serving the healthcare industry, has appointed Joe Santoro as creative director. Previously, Mr. Santoro served as a creative lead for Refinery. He is a graduate of the Philadelphia College of Art. Miles West Y Brand Names Customer Insight Planner Miles West has been named senior VP, customer insight planner, for Y Brand, New York, a strategic consulting and branding services company and part of the inChord Communications division of Ventiv Health. Most recently, he was VP, group creative director, at Corbett Accel Advertising. Mr. West has a bachelor’s degree from Syracuse University. CRO POOL Dr. Ute Berger Dr. Teresa DeLuca Dr. Cynthia Kirk Dr. Monika M. Pietrek Dr. Anthony Risser Bruce Teplitzky PRA Hires and Promotes PRA International, a global CRO with headquarters in Reston, Va., has enhanced its capacity with the promotion and addition of several staff members. Ute Berger, M.D., has joined PRA as director of global product development services, oncology. She previously served as medical coordinator at the Study Center of the German CML Study Group and managing director of the German Competence Network Acute and Chronic Leukemias. She earned her M.D. from the University of Heidelberg and is certified in internal medicine, hematology, and internal oncology. Teresa DeLuca, M.D., has joined PRA as senior director of global product development services, CNS. Most recently, Dr. DeLuca worked at GlaxoSmithKline as a research and development liaison to key opinion leaders and investigators. A board-certified psychiatrist, she received her M.D. from St. George’s University School of Medicine. Cynthia Kirk, Ph.D., has joined PRA as VP of global regulatory affairs. Dr. Kirk is currently president-elect of the Drug Information Association. Most recently, she was VP of regulatory affairs at Sepracor. She has a Ph.D. in pharmaceutical sciences, with a concentration in pharmacology/toxicology, from the University of Missouri-Kansas City. Monika M. Pietrek, M.D., Ph.D., has been promoted to executive VP of global scientific and medical affairs. In this position, Dr. Pietrek directs the company’s product-development consulting, medical and safety oversight, regulatory strategies, and late-stage development services. Additionally, PRA has hired Anthony Risser, Ph.D., as director of global product development services, CNS. Dr. Risser joins PRA from the University of Houston, where he directed distance learning courses in biopsychology. He has a Ph.D. in clinical neuropsychology from the University of Victoria. Bruce Teplitzky has been promoted to executive VP of business development, responsible for proposal and contracts management, marketing, and strategic business development. Gregg Dearhammer Kendle Appoints Head of Biometrics Unit Kendle, a global, full-service CRO based in Cincinnati, has named Gregg Dearhammer to the newly created position of VP of biometrics. Mr. Dearhammer leads Kendle’s new global biometrics operating unit. Since joining Kendle in 1996, Mr. Dearhammer has held several positions, and he most recently served as project group leader responsible for biometrics services in North and Latin America. He has a B.S. in biology from Loyola University in Chicago and is completing an M.S. in business administration at Northern Kentucky University. Dr. John C. Ho Charles River Names Senior VP Charles River Laboratories International, Wilmington, Mass., has appointed John C. Ho, M.D., as senior VP of corporate strategy. Dr. Ho leads the worldwide strategic planning process for Charles River, a global provider of solutions that advance the drug-discovery and development processes. Most recently, he served as a partner in Accenture’s Health and Life Sciences Practice. He has an MBA from the Amos Tuck School at Dartmouth College, a medical degree from Brown University School of Medicine, and a B.S. from the Massachusetts Institute of Technology. Dr. Harris Koffer Medifacts Appoints Key Executive Harris Koffer, Pharm.D., has been named executive VP of Medifacts International and president of the company’s cardiac safety services division. He comes to the Rockville, Md.-based CRO from Quest Diagnostics, where he was VP of clinical trials and pharma business development. He earned his B.S. in pharmacy and his Pharm.D. degrees from the Philadelphia College of Pharmacy and Science. He also completed a fellowship in clinical pharmacology at Thomas Jefferson University Hospital. Dr. Martine Ortéga Ventana Expands Executive Leadership Ventana Clinical Research, Toronto, a full-service clinical research organization specializing in Phase I and CNS drug development, has named an executive manager. Martine Ortéga, Pharm.D., has been appointed chief compliance officer. Dr. Ortéga has 17 years of research experience and is responsible for ensuring regulatory compliance by developing and implementing regulatory strategies, processes, and procedures. Deborah Tanner Covance Central Laboratory Appoints President Covance, a comprehensive drug-development services company based in Princeton, N.J., has promoted Deborah Tanner to corporate senior VP and president of Central Laboratory Services. She succeeds Steve Sullivan, who has taken a position at Harlan Sprague Dawley. Ms. Tanner’s career at Covance began in 1987. She most recently served as VP of global clinical trial management services and operations for Central Laboratories. She earned dual undergraduate degrees in life sciences/chemistry and business administration and accounting, as well as an MBA from the University of Wisconsin, Madison. Sara Vidmar PPD Medical Device Names Executive Director PPD, Wilmington, N.C., has appointed Sara Vidmar as executive director of PPD Medical Device. PPD is a global CRO providing discovery and development services, market development expertise, and compound partnering programs. Ms. Vidmar oversees study design, regulatory consulting, global trial management, clinical monitoring, data management, biostatistics, and document development. She most recently was director, clinical research, in the division of cardiac surgery at St. Jude Medical Center. Contract-Sales POOL Michael Cotton Larry Perini PDI Adds Executive Directors PDI, Saddle River, N.J., a diversified sales and marketing services provider to the biopharmaceutical industry, has hired Michael Cotton as executive director of business development. Mr. Cotton identifies and cultivates prospective client relationships. He has an MBA in marketing from Fairleigh Dickinson University and a B.S. in chemical engineering from Northeastern University. PDI also has hired Larry Perini as an executive director in the expanding business development unit of PDI Performance Sales Teams. In this position, Mr. Perini is responsible for identifying and cultivating prospective client relationships. He has more than 20 years of experience in business development, sales management, and operations. He is a graduate of St. John’s University. Media POOL Megan Duncan Jobson Medical Group Builds Sales Team The Jobson Medical Group (JMG), Bloomfield, N.J., has hired Megan Duncan as the account manager of Pulmonary Reviews. JMG is part of Jobson Medical Information, a specialty healthcare communications, publishing, and medical-education company. Ms. Duncan previously worked as a media planner for Conectics. She is a graduate of Bloomsburg University. Medical-Education POOL Eileen Hernández CRG Promotes Client Services Director The Curry Rockefeller Group (CRG), Tarrytown, N.Y., has promoted Eileen Hernández to senior client services director. Dedicated to thought-leader-focused medical education, CRG is a primary source of education and training for healthcare practitioners. Bill Mino CME Appoints Executive VP CME has appointed Bill Mino as executive VP, responsible for overseeing all operational and business activities. Based in Irvine, Calif., CME provides fully accredited continuing medical education programs. Mr. Mino previously was VP and general manager at Insight Medical Communications. David Murphy Pri-Med Appoints VP M|C Communications, the Boston-based producer of Pri-Med continuing medical education programs, has named David Murphy VP of account services. In this position, he manages relations with the commercial supporters of Pri-Med’s live, online, and print CME programs. Mr. Murphy most recently was a marketing director with Genzyme. Mr. Murphy has a B.S. in economics from Holy Cross and an MBA from Boston University. Katie Pierson Scienta Names Senior Program Manager Katie Pierson has been named to senior program manager at Scienta Healthcare Education, Durham, N.C., an ACCME-accredited provider of continuing medical education. Previously, Ms. Pierson was director of program development at Interactive Network for Continuing Education. Christopher Tama ProCom Appoints President ProCom, Parsippany, N.J., a CommonHealth medical-education unit, has appointed Christopher Tama as president. Mr. Tama has 25 years of pharmaceutical industry experience in sales, marketing, market research, and product and corporate development. Most recently, he was executive VP and general manager of PDI. Service POOL Dr. Johan Baeck Katie Pierson Scienta Names Senior Program Manager Katie Pierson has been named to senior program manager at Scienta Healthcare Education, Durham, N.C., an ACCME-accredited provider of continuing medical education. Previously, Ms. Pierson was director of program development at Interactive Network for Continuing Education. Christopher Tama ProCom Appoints President ProCom, Parsippany, N.J., a CommonHealth medical-education unit, has appointed Christopher Tama as president. Mr. Tama has 25 years of pharmaceutical industry experience in sales, marketing, market research, and product and corporate development. Most recently, he was executive VP and general manager of PDI. Service POOL Dr. Johan Baeck CHS Builds Marketing Professionals Team CHS, a Scottsdale, Ariz.-based provider of pharmaceutical and biotech contract marketing services, has added Johan Baeck, M.D., to its team of marketing professionals. CHS is part of the inChord Communications division of Ventiv Health. Dr. Baeck most recently served as North America and global marketing director for Pharmion. Tim Edbrooke Karen Fender Karen LeSieur TVG Appoints Senior Management Team TVG Marketing Research & Consulting, a brand knowledge firm based in Dresher, Pa., has appointed a senior management team. The new team includes Tim Edbrooke, senior VP of strategic account management and marketing; Karen Fender, senior VP of research excellence; and Karen LeSieur, senior VP of strategic marketing and development. Mr. Edbrooke was most recently with GfK Market Measures, where he was head of business development. He earned a B.Sc. in animal physiology and biochemistry from Queen Mary College, University of London. Ms. Fender previously was VP of P/S/L Research, where she worked in the portfolio marketing and development group. She graduated from Villanova University with a B.A. in communications. Ms. LeSieur has been with TVG since 2001. She leads the faculty of the TVG Marketing Seminar Series. She has a B.A. from Duke University. Susan Grosso TNS Healthcare Adds to Team TNS Healthcare hired Susan Grosso as VP of business development, responsible for bringing TNS Healthcare’s global market-research services to pharmaceutical and healthcare companies. TNS Healthcare, New York, offers a suite of services to support pharmaceutical, biotech, and device companies across the full life cycle. Ms. Grosso comes to TNS Healthcare from ImpactRx, where she served as senior director, business development. She has a B.S. in statistics, mathematics, and economics from the University of Reading in England. Terrell Herring Tristen Herrstrom Paul Mignon Bill Shearer Ventiv Commercial Services Promotes Ventiv Commercial Services, Somerset, N.J., a provider of sales, marketing, analytical, and compliance solutions for the pharmaceutical and biotech industries, has promoted several staff members. Terrell Herring has been appointed as president and CEO of Ventiv Commercial Services. Tristen Herrstrom has been appointed executive VP of resource management. She previously was responsible for leading several mergers. Paul Mignon has been named president and chief operating officer of Ventiv Pharma Teams. In other news, Bill Shearer has been named president and chief operating officer of Ventiv Pharma Services. Mr. Shearer is responsible for the Franklin Group, Pharmaceutical Resource Solutions, and Promotech divisions of Ventiv Commercial Services. Technology POOL Dr. William Bachman Dr. John Warner Pharsight Adds Staff Pharsight, Mountain View, Calif., a provider of software and strategic services for optimizing clinical-drug development, has added two staff members. William Bachman, Ph.D., has been named senior scientific consultant in Pharsight’s product-training organization. He most recently worked in the GloboMax division of Icon. Dr. Bachman has a Ph.D. in pharmacy from the University of Georgia. Pharsight has hired John Warner, Ph.D., as senior scientist in strategic consulting services in the United States. Dr. Warner most recently worked for Novartis. He has a Ph.D. in statistics, an M.A. in mathematics, and a B.S. in mathematics from the University of Michigan at Ann Arbor. F Please send your personnel announcements to feedback@pharmavoice.com.

Posted in:

Post a Comment

You must be logged in to post a Comment.